Victoria A. Johnson

Best Publications

• Viral dynamics in human immunodeficiency virus type 1 infection

  Xiping Wei;Sajal K. Ghosh;Maria E. Taylor;Victoria A. Johnson

  4345
  Citations

• Update of the Drug Resistance Mutations in HIV-1.

  Victoria A Johnson;Francoise Brun-Vezinet;Bonaventura Clotet;Huldrych F Gunthard

  1980
  Citations

• 2017 Update of the Drug Resistance Mutations in HIV-1.

  Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  873
  Citations

• 2014 Update of the drug resistance mutations in HIV-1.

  Annemarie M Wensing;Vincent Calvez;Huldrych F Günthard;Victoria A Johnson

  841
  Citations

• 2015 Update of the Drug Resistance Mutations in HIV-1.

  Annemarie M. Wensing;Vincent Calvez;Huldrych F. Günthard;Victoria A. Johnson

  766
  Citations

• Antiretroviral drug resistance testing in adults with HIV infection: Implications for clinical management

  M S Hirsch;B Conway;R T D'Aquila;V A Johnson

  741
  Citations

• Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel.

  Martin S. Hirsch;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  674
  Citations

• Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection: 2008 Recommendations of an International AIDS Society-USA Panel

  Martin S. Hirsch;Huldrych F. Günthard;Jonathan M. Schapiro;Francoise Brun-Vezinet

  664
  Citations

• HIV infection is blocked in vitro by recombinant soluble CD4

  Richard A. Fisher;Jeanne M. Bertonis;Werner Meier;Victoria A. Johnson

  593
  Citations

• Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Working Group.

  A J Japour;D L Mayers;V A Johnson;D R Kuritzkes

  467
  Citations

• Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.

  Paul E. Sax;Camlin Tierney;Ann C. Collier;Margaret A. Fischl

  429
  Citations

• Drug Resistance Mutations in HIV-1.

  Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  360
  Citations

• Antiretroviral Drug Resistance Testing in Adult HIV-1 Infection

  Martin S. Hirsch;Scott M. Hammer;Victoria A. Johnson;Daniel R. Kuritzkes

  332
  Citations

• Use of Changes in Plasma Levels of Human Immunodeficiency Virus Type 1 RNA to Assess the Clinical Benefit of Antiretroviral Therapy

  Ian C. Marschner;Ann C. Collier;Robert W. Coombs;Richard T. D'Aquila

  331
  Citations

• Update of the drug resistance mutations in HIV-1: March 2013.

  Victoria A Johnson;Vincent Calvez;Huldrych F Gunthard;Roger Paredes

  329
  Citations

• Comparison of Four-Drug Regimens and Pairs of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

  Robert W. Shafer;Laura M. Smeaton;Gregory K. Robbins;Victor De Gruttola

  311
  Citations

• A randomized trial to study first-line combination therapy with or without a protease inhibitor in HIV-1-infected patients.

  Remko Van Leeuwen;Christine Katlama;Robert Murphy;Kathleen Squires

  271
  Citations

• Pre-existing Minority Drug-Resistant HIV-1 Variants, Adherence, and Risk of Antiretroviral Treatment Failure

  Roger Paredes;Roger Paredes;Christina M. Lalama;Heather J. Ribaudo;Bruce R. Schackman

  254
  Citations

• Update of the drug resistance mutations in HIV-1: 2007.

  Victoria A Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Huldrych F Günthard

  249
  Citations

• Update of the drug resistance mutations in HIV-1: Fall 2005.

  Victoria A. Johnson;Françoise Brun-Vézinet;Bonaventura Clotet;Brian Conway

  224
  Citations